Becton Dickinson & Company, headquartered in Franklin Lakes, New Jersey, is a global leader in developing, manufacturing, and selling a wide range of medical supplies, devices, laboratory equipment, and diagnostic products. Its offerings support healthcare institutions, physicians, life science researchers, and the pharmaceutical industry. The company operates across three main segments: BD Medical, focusing on products for IV therapy and medication management; BD Life Sciences, providing tools for blood collection and diagnostics; and BD Interventional, offering surgical and critical care products. Founded in 1897, it plays a crucial role in advancing medical discovery and care.
Four Dividend Aristocrats were flagged as stealth growth plays a year ago, and the results cut sharply in two directions. See which names delivered and which stumbled, plus three fresh picks where…
Wall Street analysts are busy reshuffling their ratings ahead of the Fed meeting, with surprise double-upgrades, dramatic target cuts, and fresh initiations spanning surgical robots to cybersecurity. Find out which names made…
Wall Street has gotten far more selective on AI stocks, but these AI stocks are still receiving the lion’s share of invested capital. Dividend Aristocrat stocks like PepsiCo (NASDAQ:PEP | PEP Price…
Dividend Kings are stocks that’ve had their dividend payouts raised for 50 consecutive years or more, such as Target (NYSE:TGT | TGT Price Prediction), Becton Dickinson (NYSE:BDX), and Hormel Foods (NYSE:HRL). That…
Dividend Aristocrats are some of the best stocks to buy when they go on sale, as they’re backed by companies on a solid footing. These companies have raised the dividends on their…
Wall Street feels these five Dividend Aristocrat stocks are the best values in the group and offer the best entry points for investors seeking dependable income with growth potential.
With all of the attention focused on the Magnificent 7 tech stocks, AI, and biotech stocks that are all high flying and turbo charging the S&P 500, it’s easy to overlook other…
As we enter the second half of 2025, now is the perfect time to invest in dividend stocks — especially those with quality underlying fundamentals that pay high dividend yields. Many such…
Certain stocks have declined significantly in the past few months as the economic cycle has been changing. The Federal Reserve seems well-positioned to do at least one rate cut this year. Inflation…
Live Updates Amazon Works to Keep the Bubble Afloat4:09pm ETAnd that’s a wrap for Thursday. The market has closed, and the S&P 500 ended up hanging on to most of its gains…
Tuesday's top analyst upgrades and downgrades included American Express, Apple, AppLovin, Conagra Brands, D.R. Horton, Estee Lauder, Juniper Networks, Livent, Microsoft, Netflix, Nvidia, Shopify, Tesla, and Twilio.
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson, Kenvue and Medtronic.
Monday's top analyst upgrades and downgrades included Apple, Atlassian, Block, CF Industries, Comerica, DraftKings, Exact Sciences, Global Payments, Kellogg, Mobileye Global, Shopify, VFC and Zions Bancorp.
Thursday's top analyst upgrades and downgrades included Alcoa, Archer Daniels Midland, Bill, Block, Confluent, Dow, Foot Locker, Huntsman, Las Vegas Sands, LyondellBasell Industries, Raytheon Technologies, Realty Income, Shopify and Wheaton Precious Metals.
Tuesday's top analyst upgrades and downgrades included Accenture, Analog Devices, Apple, Baxter International, Best Buy, Coterra Energy, Emerson Electric, Johnson Controls, Lam Research, Micron Technology, Qualcomm, Silvergate Capital, Tapestry and Walt Disney.
